HI homepage

breast cancer month ribbon

The recommendations were designed to improve accuracy and safety in diagnosing breast lesions using multiple imaging methods, including DBT, ultrasound and MRI. 

Ultrasound exam with patient. Siemens RSNA 23. Photo by Dave Fornell. #RSNA #RSNA23 #RSNA2023

New data published in Emergency Radiology suggest this common practice could skew the results of some scans.

Researchers using 4D MRI technology to test artificial hearts.

Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.

hospital safety leapfrog group

Researchers believe that it could be especially beneficial in patients with impaired kidney function who may be at risk of adverse reactions to standard ICM.

Example of the four types of breast tissue density. The density of fibroglandular tissue inside the breast impacts the ability to easily see cancers. Cancers are very easy to spot in fatty breasts, but are almost impossible to find in extremely dense breasts. These examples show craniocaudal mammogram findings characterized as almost entirely fatty (far left), scattered areas of fibroglandular density (second from left), heterogeneously dense (second from right), and extremely dense (far right). RSNA

The modality often detects clinically important disease that is missed on standard 3D mammogram screening exams.

partnership business deal joint venture

The medical tech giant on Monday announced their partnership with the Aloha State’s largest private health care provider and private employer. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.